Les Laboratoires Servier SAS - Strategic SWOT Analysis Review

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - The publisher's summarization of the company’s business strategy.
SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Les Laboratoires Servier SAS (Servier) researches, develops, manufactures, and markets drugs for treating various diseases. The company's portfolio of marketed products treats central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, hematological disorders, hormonal disorders, and others. It invests a substantial amount of revenue in R&D. Servier operates research centers in France and Hungary; and International Centers for Therapeutic Research (ICTRs). The company also provides generic drugs and contract development and manufacturing services across its global network. The company also provides digital therapeutic solutions through its e-health division, WeHealth Digital Medicine. It sells products in Europe, America, Middle East, Africa, and Asia. Servier headquartered in Suresnes, France

Les Laboratoires Servier SAS Key Recent Developments

Dec 15, 2022: OPM and Servier launch "FederAidd", an international virtual campus for open innovation to accelerate and make the drug discovery process more reliable thanks to Artificial Intelligence
Dec 14, 2022: Servier joins forces with Gustave Roussy to develop research programs in oncology
Oct 12, 2022: Servier and HealthTech For Care, a shared commitment to accelerate therapeutic innovation
Oct 06, 2022: Servier unveils its 2030 ambition and reveals a new visual identity

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Section 1 - About the Company

Les Laboratoires Servier SAS - Key Facts
Les Laboratoires Servier SAS - Key Employees
Les Laboratoires Servier SAS - Key Employee Biographies
Les Laboratoires Servier SAS - Major Products and Services
Les Laboratoires Servier SAS - History
Les Laboratoires Servier SAS - Company Statement
Les Laboratoires Servier SAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview
Les Laboratoires Servier SAS - Business Description
Product Category: Branded Medicines
Performance
Product Category: Generic Medicines
Performance
Geographical Segment: Africa and Middle East
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia and Oceania
Performance
Geographical Segment: Europe (Outside the EU)
Performance
Geographical Segment: European Union
Performance
Les Laboratoires Servier SAS - SWOT Analysis
SWOT Analysis - Overview
Les Laboratoires Servier SAS - Strengths
Les Laboratoires Servier SAS - Weaknesses
Les Laboratoires Servier SAS - Opportunities
Les Laboratoires Servier SAS - Threats
Les Laboratoires Servier SAS - Key Competitors

Section 3 - Company’s Lifesciences Financial Deals and Alliances

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Les Laboratoires Servier SAS, Recent Deals Summary

Section 4 - Company’s Recent Developments

Dec 15, 2022: OPM and Servier launch"FederAidd", an international virtual campus for open innovation to accelerate and make the drug discovery process more reliable thanks to Artificial Intelligence
Dec 14, 2022: Servier joins forces with Gustave Roussy to develop research programs in oncology
Oct 12, 2022: Servier and HealthTech For Care, a shared commitment to accelerate therapeutic innovation
Oct 06, 2022: Servier unveils its 2030 ambition and reveals a new visual identity
Sep 16, 2022: Servier backs a Californian startup research project to accelerate therapeutic innovation
Aug 26, 2022: Servier on the front line of cardiovascular disease prevention and therapeutic adherence
Jun 23, 2022: Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting
Jun 15, 2022: Servier : Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
Jun 01, 2022: Patient associations’ perception of pharmaceutical companies: Servier is making progress
Apr 27, 2022: Appointment of Walid S. Kamoun, PhD. MSc., Global Head of Servier R&D Oncology

Section 5 - Appendix

Methodology
About the Publisher
Contact the Publisher
Disclaimer

List of Tables

Les Laboratoires Servier SAS, Key Facts
Les Laboratoires Servier SAS, Key Employees
Les Laboratoires Servier SAS, Key Employee Biographies
Les Laboratoires Servier SAS, Major Products and Services
Les Laboratoires Servier SAS, History
Les Laboratoires Servier SAS, Subsidiaries
Les Laboratoires Servier SAS, Key Competitors
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Les Laboratoires Servier SAS, Recent Deals Summary

List of Figures

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023